YAP1 and cancer: Recent research identifies three levels of contributing factors: (1) Tissue or cancer specificity of endogenous core YAP binding partners: particularly notable are the TEAD family, consisting of TEAD1-4, and the VGLL family, comprising VGLL1-4.